Success Story: NAILG Experts got the EB1-B Petition Approved in less than a month for a Research Associate from China in the Field of Chromatin Biology without any request for Premium Processing
Client’s Testimonial:
“Thank you so much for confirming the approval. That is great to know.”
On February 13th, 2023, we received another EB-1B (Outstanding Professors and Researchers) approval for a Research Associate in the Field of Chromatin Biology (Approval Notice).
General Field: Chromatin Biology
Position at the Time of Case Filing: Research Associate
Country of Origin: China
State of Residence at the Time of Filing: New York
Approval Notice Date: February 13th, 2023
Processing Time: 27 days
Case Summary:
A research associate in the field of chromatin biology approached us to file her EB-1B (Outstanding Professors and Researchers) petition. We made sure that she receives the best legal advice for the same.
To be qualified for the EB1-B category, the petition must:
- Show international recognition as being outstanding in a specific academic area;
- The foreign national must have at least 3 years of experience in teaching or researching in the academic area;
- While no labor certification is required, there must be an offer of ongoing employment from the sponsoring employer.
Therefore, after reviewing her credentials, we found that our client has accumulated an impressive record of success:
- She received her Ph.D. in molecular and developmental biology.
- Her work has resulted in 11 peer-reviewed scientific articles.
- Her publications have been cited 466 times according to Google Scholar, thereby signifying that these publications are widely acknowledged and counted upon in the field of her expertise.
- She has conducted at least 22 reviews to date.
Additionally, our client’s research addresses some of our nation’s most pressing issues in healthcare, in particular, the burden of cancer. Her strong background in molecular and developmental biology has allowed her research to be particularly original, with applications such as improved cancer treatment. She is particularly well-known for her identification and characterization of cancer-associated mutations.
Leading researchers from top universities and research groups from the United States and abroad have also submitted letters for her as one out of four stated:
“I am pleased to submit this letter as a recommendation for the prolonged support of [the client’s] research in the United States of America. Based on her breadth of experience, the influence that her work has had in the scientific community, and the resounding global impact of her research, it is clear that she is operating at the top of her field.”
We are confident that she is more than capable of furthering her knowledge base in her chosen field and continuing her work in the United States of America. She received her EB-1B approval in 27 days only that too without requesting any premium processing.
We would like to thank her for her sustained presence in the whole immigration process and wish her good luck in her future endeavors.